<!doctype html><html lang=en-us dir=ltr><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta name=description content="Overview # To avoid tissue injury, the inflammatory response needs to be controlled and regulated.
There are mechanisms in place to control, regulate, and eventually terminate the inflammatory response:
mediators are produced in rapid bursts (not continous) release is stimulus dependent short half-lives degrade after release neutrophil/PMN short life production of stop signals at the end of IR there are neural inhibitors There are major general features of mediators of inflammation:"><meta name=theme-color content="#FFFFFF"><meta name=color-scheme content="light dark"><meta property="og:title" content><meta property="og:description" content="Overview # To avoid tissue injury, the inflammatory response needs to be controlled and regulated.
There are mechanisms in place to control, regulate, and eventually terminate the inflammatory response:
mediators are produced in rapid bursts (not continous) release is stimulus dependent short half-lives degrade after release neutrophil/PMN short life production of stop signals at the end of IR there are neural inhibitors There are major general features of mediators of inflammation:"><meta property="og:type" content="article"><meta property="og:url" content="https://axolotz.github.io/mednotes/docs/notes/y2/s1/pathology/3.-mediators/"><meta property="article:section" content="docs"><title>3. Mediators | Axolotz's Med Notes</title><link rel=manifest href=/mednotes/manifest.json><link rel=icon href=/mednotes/favicon.png type=image/x-icon><link rel=stylesheet href=/mednotes/book.min.c58292d36b18b675680ab9baea2029204537b839ea72f258746ec0f32ce8d6c8.css integrity="sha256-xYKS02sYtnVoCrm66iApIEU3uDnqcvJYdG7A8yzo1sg=" crossorigin=anonymous><script defer src=/mednotes/flexsearch.min.js></script>
<script defer src=/mednotes/en.search.min.0d1f8499a032ed94686dd2113368f3aecddc7babcc3cf6f869c6b6f0ff72cbb1.js integrity="sha256-DR+EmaAy7ZRobdIRM2jzrs3ce6vMPPb4aca28P9yy7E=" crossorigin=anonymous></script></head><body dir=ltr><input type=checkbox class="hidden toggle" id=menu-control>
<input type=checkbox class="hidden toggle" id=toc-control><main class="container flex"><aside class=book-menu><div class=book-menu-content><nav><h2 class=book-brand><a class="flex align-center" href=/mednotes/><span>Axolotz's Med Notes</span></a></h2><div class=book-search><input type=text id=book-search-input placeholder=Search aria-label=Search maxlength=64 data-hotkeys=s/><div class="book-search-spinner hidden"></div><ul id=book-search-results></ul></div><ul><li class=book-section-flat><a href=/mednotes/docs/home/>Home</a><ul></ul></li><li class=book-section-flat><span>Notes</span><ul><li><input type=checkbox id=section-4d3c552ac538c474e5e7984bb3257809 class=toggle checked>
<label for=section-4d3c552ac538c474e5e7984bb3257809 class="flex justify-between"><a role=button>Y2</a></label><ul><li><input type=checkbox id=section-a1667d2f454cd998c80883b545ef0d14 class=toggle checked>
<label for=section-a1667d2f454cd998c80883b545ef0d14 class="flex justify-between"><a role=button>S1</a></label><ul><li><input type=checkbox id=section-ad3e5840875ebfa14c136aa6f69a1833 class=toggle>
<label for=section-ad3e5840875ebfa14c136aa6f69a1833 class="flex justify-between"><a role=button>Bacteriology</a></label><ul></ul></li><li><input type=checkbox id=section-fa718ff1169745fc0a845d1e7cf5dadb class=toggle>
<label for=section-fa718ff1169745fc0a845d1e7cf5dadb class="flex justify-between"><a role=button>Community Medicine</a></label><ul><li><a href=/mednotes/docs/notes/y2/s1/community-medicine/1.-intro/>1. Intro</a></li><li><a href=/mednotes/docs/notes/y2/s1/community-medicine/2.-primary-health-care/>2. Primary Health Care</a></li></ul></li><li><input type=checkbox id=section-ea2aa1d7a5bfbc5d12f81bb7c28a7dac class=toggle>
<label for=section-ea2aa1d7a5bfbc5d12f81bb7c28a7dac class="flex justify-between"><a role=button>Immunology</a></label><ul></ul></li><li><input type=checkbox id=section-037ebedc4997c971e6cefe20802167c3 class=toggle>
<label for=section-037ebedc4997c971e6cefe20802167c3 class="flex justify-between"><a role=button>Metabolism</a></label><ul></ul></li><li><input type=checkbox id=section-7f513c223eb737b520e7feabb95f38d7 class=toggle checked>
<label for=section-7f513c223eb737b520e7feabb95f38d7 class="flex justify-between"><a role=button>Pathology</a></label><ul><li><a href=/mednotes/docs/notes/y2/s1/pathology/1.-inflammation-overview/>1. Inflammation Overview</a></li><li><a href=/mednotes/docs/notes/y2/s1/pathology/2.-acute-inflammation/>2. Acute Inflammation</a></li><li><a href=/mednotes/docs/notes/y2/s1/pathology/3.-mediators/ class=active>3. Mediators</a></li></ul></li><li><input type=checkbox id=section-420d3ff3d47cb5fca6a70fddcee937c5 class=toggle>
<label for=section-420d3ff3d47cb5fca6a70fddcee937c5 class="flex justify-between"><a role=button>Pharmacology</a></label><ul></ul></li><li><input type=checkbox id=section-5946013515f24729b48c3543c352bcba class=toggle>
<label for=section-5946013515f24729b48c3543c352bcba class="flex justify-between"><a role=button>Virology</a></label><ul></ul></li></ul></li></ul></li></ul></li></ul></nav><script>(function(){var e=document.querySelector("aside .book-menu-content");addEventListener("beforeunload",function(){localStorage.setItem("menu.scrollTop",e.scrollTop)}),e.scrollTop=localStorage.getItem("menu.scrollTop")})()</script></div></aside><div class=book-page><header class=book-header><div class="flex align-center justify-between"><label for=menu-control><img src=/mednotes/svg/menu.svg class=book-icon alt=Menu></label>
<strong>3. Mediators</strong>
<label for=toc-control><img src=/mednotes/svg/toc.svg class=book-icon alt="Table of Contents"></label></div><aside class="hidden clearfix"><nav id=TableOfContents><ul><li><a href=#overview><strong>Overview</strong></a></li><li><a href=#arachidonic-acid-metabolites><strong>Arachidonic Acid Metabolites</strong></a><ul><li><a href=#cox-products><strong>COX Products</strong></a></li><li><a href=#lox-products><strong>LOX Products</strong></a></li><li><a href=#pharmacologic-inhibitors><strong>Pharmacologic Inhibitors</strong></a></li></ul></li><li><a href=#cytokines><strong>Cytokines</strong></a><ul><li><a href=#major-effects><strong>Major Effects</strong></a></li><li><a href=#chemokines><strong>Chemokines</strong></a></li></ul></li><li><a href=#complement-system><strong>Complement System</strong></a><ul><li><a href=#activation-pathways><strong>Activation Pathways</strong></a></li><li><a href=#functions><strong>Functions</strong></a></li><li><a href=#regulation><strong>Regulation</strong></a></li></ul></li></ul></nav></aside></header><article class=markdown><h2 id=overview><strong>Overview</strong>
<a class=anchor href=#overview>#</a></h2><hr><p>To avoid tissue injury, the inflammatory response needs to be controlled and regulated.</p><p>There are mechanisms in place to control, regulate, and eventually terminate the inflammatory response:</p><ul><li>mediators are produced in rapid bursts (not continous)</li><li>release is stimulus dependent</li><li>short half-lives</li><li>degrade after release</li><li>neutrophil/PMN short life</li><li>production of stop signals at the end of IR</li><li>there are neural inhibitors</li></ul><p>There are major general features of mediators of inflammation:</p><ul><li>derived at site of injury</li><li>plasma proteins need activation, active mediators need stimulation</li><li>most mediators have short lifespan</li><li>one can activate the other</li></ul><blockquote><p><em>Somewhere along this point the prof. puts up a table of mediators that we are supposed to know. Leave it for now, study it at the end of mediators, it will be easier after you go through the lesson. You will be a lot more familiar with them, and they will be easier to remember.</em></p></blockquote><h2 id=arachidonic-acid-metabolites><strong>Arachidonic Acid Metabolites</strong>
<a class=anchor href=#arachidonic-acid-metabolites>#</a></h2><hr><p>The lipid mediators prostaglandins and leukotrienes are produced from arachidonic acid, they stimulate vascular and cellular rxns in acute inflammation.</p><p>Mediators derived from arachidonic acid are called eicosanoids (prof. hates that name).</p><ul><li>Arachidonic acid is present in membrane phospholipids.</li><li>A stimulus or mediator (e.g: C5a) can trigger the release of that arachidonic acid by activating phospholipase.</li><li>Phospholipase damages the membrane, releasing the arachidonic acid.</li></ul><ul><li>Once out of the membrane, enzymes rapidly convert arachidonic acid into bioactive mediators.</li><li>These enzymes are either cyclooxygenases or lipoxygenases.<ul><li>cyclooxygenases generate prostaglandins</li><li>lipoxygenases produce leukotrienes and lipoxins</li></ul></li></ul><p>To sum up: arachidonic acid exists inside the phospholipid membrane. A stimulus acivates phospholipase, damaging the membrane, which releases the acid. Enzymes then convert the acid into mediators. This can go two ways, either the enzyme is a cyclooxygenase or a lipoxygenase. Depending on the enzyme you get different mediators.</p><table><thead><tr><th style=text-align:center><img src=https://i.pinimg.com/originals/5f/5e/14/5f5e14d84d9732b609ea162ac56bcfdc.jpg alt></th></tr></thead><tbody><tr><td style=text-align:center><em>production of AA metabolites and their role in inflammation</em></td></tr></tbody></table><h3 id=cox-products><strong>COX Products</strong>
<a class=anchor href=#cox-products>#</a></h3><p>See image above for reference.</p><ul><li>PGI2 causes vasodilation while TXA2 causes vasoconstriction</li><li>PGI2 inhibits platelet aggregation, while TXA2 promotes platelet aggregation</li></ul><ul><li>An imbalance between PGI2 and TXA2 can possibly cause ischemic heart disease atherosclerosis or cerebrovascular accident (stroke)</li></ul><blockquote><p><em>professor mentioned that PGI2 and TXA2 will come on the exam</em></p></blockquote><p>PGD2 and PGE2 have a less critical function, they serve to vasodilate and increase vascular permeability.</p><h3 id=lox-products><strong>LOX Products</strong>
<a class=anchor href=#lox-products>#</a></h3><p>Lipooxygenase products include leukotrienes (LT) and lipoxins</p><ul><li>LTB4&rsquo;s main function is as a chemoattractant for chemotaxis</li><li>LTC4, D4, E4 play a role in bronchospasms and increase in vasc. permeability<ul><li>thus they are targeted for therapy to control asthma attacks</li></ul></li></ul><p>Lipoxin A4 and Lipoxin B4 make general inhibition of inflammation,
particularly anti-chemotaxis.</p><table><thead><tr><th style=text-align:center>Action</th><th style=text-align:center>Eicosanoid/AA Metabolite</th></tr></thead><tbody><tr><td style=text-align:center>Vasodilation</td><td style=text-align:center>PGI2, PGE1, PGE2, PGD2</td></tr><tr><td style=text-align:center>Vasoconstriction</td><td style=text-align:center>TXA2, leukotrienes C4, D4, E4</td></tr><tr><td style=text-align:center>Increased vascular permeability</td><td style=text-align:center>leukotrienes C4, D4, E4</td></tr><tr><td style=text-align:center>Chemotaxis, leukocyte adhesion</td><td style=text-align:center>LTB4</td></tr><tr><td style=text-align:center>Smooth muscle contraction</td><td style=text-align:center>Prostaglandins C4, D4, E4</td></tr></tbody></table><h3 id=pharmacologic-inhibitors><strong>Pharmacologic Inhibitors</strong>
<a class=anchor href=#pharmacologic-inhibitors>#</a></h3><p>As seen in the image above, some drugs target this process.</p><ul><li>Steroids<ul><li>very strong and potent anti-inflamamtory drugs</li><li>inhibit phospholipase</li><li>thus entirely inhibit both pathways</li></ul></li></ul><ul><li>COX-1 and COX-2 inhibitors, aspirin, indomethacin<ul><li>called &ldquo;anti-prostaglandins&rdquo;</li><li>inhibit cyclooxygenases</li><li>thus only inhibit prostaglandin production</li></ul></li></ul><ul><li>Lipooxygenase inhibitors<ul><li>inhibit lipooxygenase</li><li>thus only inhibit leukotriene and lipoxin production</li></ul></li></ul><p>Steroids are the strongest, the other two types are not as strong.</p><blockquote class="book-hint info"><p><strong>Summary (AA metabolites)</strong></p><ul><li>Aspirin inhibits cyclooxygenase (COX)</li><li>Steroids inhibit phospholipase and are anti-inflammatory</li><li>Prostacyclin (PGI2) vasodilator and inhibits platelet aggregation.</li><li>TXA2 vasoconstrictor and promotes platelet aggregation.</li><li>TXA2 and PGI2 imbalance can lead to ischemic heart disease (IHD) and CV (stroke).</li><li>PGE2 is a major mediator for pain and fever.</li></ul></blockquote><h2 id=cytokines><strong>Cytokines</strong>
<a class=anchor href=#cytokines>#</a></h2><hr><p>Cytokines are secreted by many cells predominantly activated lymphocytes, macrophages, and dendritic cells.</p><p>They mediate and regulate immune and inflamamtory response.</p><table><thead><tr><th style=text-align:center>Cytokine</th><th style=text-align:center>Principal Sources</th><th style=text-align:center>Principal Actions in Inflammation</th></tr></thead><tbody><tr><td style=text-align:center><strong>In Acute Inflammation</strong></td><td></td><td></td></tr><tr><td style=text-align:center>TNF</td><td></td><td></td></tr><tr><td style=text-align:center>IL-1</td><td></td><td></td></tr><tr><td style=text-align:center>IL-6</td><td></td><td></td></tr><tr><td style=text-align:center>Chemokines</td><td></td><td></td></tr><tr><td style=text-align:center>IL-17</td><td style=text-align:center>T lymphocytes</td><td style=text-align:center>recruitment of nuetrophils and monocytes</td></tr><tr><td style=text-align:center><strong>In Chronic Inflammation</strong></td><td></td><td></td></tr><tr><td style=text-align:center>IL-12</td><td></td><td></td></tr><tr><td style=text-align:center>IL-Î³</td><td style=text-align:center>T-lymphocytes, NK cells</td><td></td></tr><tr><td style=text-align:center>IL-17</td><td style=text-align:center>T lymphocytes</td><td style=text-align:center>recruitment of nuetrophils and monocytes</td></tr></tbody></table><h3 id=major-effects><strong>Major Effects</strong>
<a class=anchor href=#major-effects>#</a></h3><p>Cytokines can serve multiple major effects. These include:</p><ul><li>Local inflammation</li><li>Systemic protective effects</li><li>Systemic pathologic effects</li></ul><blockquote><p><em>systemic means affecting the entire body, rather than a single organ or body part</em></p></blockquote><table><thead><tr><th style=text-align:center><img src=https://media.cheggcdn.com/media/90f/90fd8a05-58c9-401a-a485-149e61d1c723/f002-017-9781437717815-1599E00DC9C7485374A.jpg alt></th></tr></thead><tbody><tr><td style=text-align:center><em>major roles of cytokines in acute inflammation</em></td></tr></tbody></table><ul><li>Local inflammation are the local effects we mentioned before</li></ul><ul><li>Systemic protective effects<ul><li>induce fever</li><li>acute-phase proteins in the liver</li><li>stimulate more hematopoietic cells in bone marrow</li></ul></li></ul><ul><li>Systemic pathologic effects<ul><li>can affect heart causing low output or heart failure</li><li>TNF may cause platelet aggregation and thrombus formation<ul><li>may cause ischemia in the heart or other organs</li></ul></li><li>TNF may also cause insulin resistance</li></ul></li></ul><h3 id=chemokines><strong>Chemokines</strong>
<a class=anchor href=#chemokines>#</a></h3><p>Family of cytokines. Small proteins, mainly chemoattractants.</p><ul><li>Act via G-protein coupled receptors</li><li>Serve 2 main functions<ul><li>inflammation</li><li>maintaining tissue architecture</li></ul></li></ul><h2 id=complement-system><strong>Complement System</strong>
<a class=anchor href=#complement-system>#</a></h2><hr><p>The complement system is a collection of soluble proteins and their membrane receptors that function mainly in host defense against microbes and in pathologic inflammatory rxns.</p><p>Complement system activation is also known as &ldquo;complement fixation&rdquo;.</p><ul><li>Inactive proteins that need activation</li><li>More than 20<ul><li>C1-C9 are the most common</li><li>C3 specifically is the most common<ul><li>cleavage of C3 activates the complement system</li></ul></li></ul></li></ul><ul><li>Important in innate and adaptive immunity</li><li>Functions<ul><li>vascular permeability</li><li>chemotaxis</li><li>opsonitzation</li></ul></li></ul><h3 id=activation-pathways><strong>Activation Pathways</strong>
<a class=anchor href=#activation-pathways>#</a></h3><p>There are 3 pathways for C3 activation (which activates the complement system cascade):</p><ul><li>Alternative pathway</li><li>Classical pathway</li><li>Lectin pathway</li></ul><table><thead><tr><th style=text-align:center><img src=https://emedicodiary.com/files/87c827ef0b9d079f92f2ed7cd3d4875a.jpg alt></th></tr></thead></table><ul><li>Alternative pathway<ul><li>triggered by bacterial polysaccharides</li></ul></li></ul><ul><li>Classical pathway<ul><li>triggered by antigen-antibody complex</li><li>invader produces antibodies, antibody joins antigens, the antigen-antibody triggers activation</li></ul></li></ul><ul><li>Lectin pathway<ul><li>triggered by mannose receptor binding to lectin</li></ul></li></ul><p>After that, activated C3 goes into 3 pathways (image above):</p><ul><li>C5a, C3a Inflammation<ul><li>C3a (active part) functions as a chemotactic agent to recruit/activate leukocytes.</li><li>This induces the production of C5a and C3a</li></ul></li></ul><ul><li>C3b Phagocytosis<ul><li>C3b is important in stimulating phagocytosis.</li><li>assists macrophages and neutrophils in phagocytosis.</li></ul></li></ul><ul><li>MAC lysis of microbe<ul><li>continous stimulation of cascade leads to activation of C5, C6, C7.</li><li>C5, C6, C7 then produce &ldquo;membrane attack complex&rdquo; (MACrophages)</li><li>MAC directly kills without the need for phagocytosis</li></ul></li></ul><h3 id=functions><strong>Functions</strong>
<a class=anchor href=#functions>#</a></h3><ul><li>Inflammation<ul><li>anphylatoxins such as C5a</li></ul></li><li>Opsonization & phagocytosis<ul><li>C3b is the strongest opsonizing agent</li></ul></li><li>Cell lysis<ul><li>MAC, made up of multiples of C9.</li><li>create pores in microbial wall that disrupt osmotic balance, killing the microbe.</li></ul></li></ul><h3 id=regulation><strong>Regulation</strong>
<a class=anchor href=#regulation>#</a></h3></article><footer class=book-footer><div class="flex flex-wrap justify-between"></div><script>(function(){function e(e){const t=window.getSelection(),n=document.createRange();n.selectNodeContents(e),t.removeAllRanges(),t.addRange(n)}document.querySelectorAll("pre code").forEach(t=>{t.addEventListener("click",function(){if(window.getSelection().toString())return;e(t.parentElement),navigator.clipboard&&navigator.clipboard.writeText(t.parentElement.textContent)})})})()</script></footer><div class=book-comments></div><label for=menu-control class="hidden book-menu-overlay"></label></div><aside class=book-toc><div class=book-toc-content><nav id=TableOfContents><ul><li><a href=#overview><strong>Overview</strong></a></li><li><a href=#arachidonic-acid-metabolites><strong>Arachidonic Acid Metabolites</strong></a><ul><li><a href=#cox-products><strong>COX Products</strong></a></li><li><a href=#lox-products><strong>LOX Products</strong></a></li><li><a href=#pharmacologic-inhibitors><strong>Pharmacologic Inhibitors</strong></a></li></ul></li><li><a href=#cytokines><strong>Cytokines</strong></a><ul><li><a href=#major-effects><strong>Major Effects</strong></a></li><li><a href=#chemokines><strong>Chemokines</strong></a></li></ul></li><li><a href=#complement-system><strong>Complement System</strong></a><ul><li><a href=#activation-pathways><strong>Activation Pathways</strong></a></li><li><a href=#functions><strong>Functions</strong></a></li><li><a href=#regulation><strong>Regulation</strong></a></li></ul></li></ul></nav></div></aside></main></body></html>